Skip to content
★ Sign in to follow
EC

Eastern Capital Ltd

Shareholder
Related company / holding
iBio, Inc.Marker Therapeutics, Inc.Bio Green Med Solution, Inc.Cytokinetics IncVericel Corp
Total declarations
24
Companies
5
▲ Purchases (9 ops.)
€17.6M
▼ Sales (6 ops.)
€83.4M

Latest filing published 11 Aug 2020 for iBio, Inc., €4.9M.

Filing timeline

BuySale
Eastern Capital Ltd

Insider track record

Disclosed buys
9
Disclosed sells
6
Signal history

Closed purchases

Market purchases
9
Positive at T+90
75%
Median T+90
+10.1%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 13 Jul 2018 · 3041 days ago · €1.7M
    -13.9%
    Entry US$395.00 · Close at T+365 US$340.00
  • Filed 28 Jun 2018 · 3056 days ago · €1.3M
    -22.2%
    Entry US$450.00 · Close at T+365 US$350.00
  • Filed 16 May 2018 · 3099 days ago · €2.6M
    +64.7%
    Entry US$34.80 · Close at T+365 US$57.30
  • Filed 04 Dec 2017 · 3262 days ago · €2.0M
    -55.3%
    Entry US$850.00 · Close at T+365 US$380.00
  • Filed 21 Jul 2017 · 3398 days ago · €1.5M
    -15.7%
    Entry US$128,160.00 · Close at T+365 US$108,000.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Eastern Capital Ltd: trading record in brief

Eastern Capital Ltd has filed trades across 5 companies (mainly through SEC (Form 4)), most often in iBio, Inc., Marker Therapeutics, Inc. and Bio Green Med Solution, Inc. Over a trading history stretching from 26 April 2013 to 11 August 2020, the count stands at 24 filings.

In open-market terms, that means 9 purchases worth €17.6M on one side and 6 sales worth €83.4M on the other. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants. Since January 2020: no purchases and 6 sales on the market.

A typical purchase (the median) is worth €2.0M. Across 7 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 8 purchases show a median change of +10.1%, with the price up in 75% of them. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 11 August 2020: an open-market sale of €24.2M, in iBio, Inc. The latest purchase dates back some time: it was published 3,041 days ago, on 13 July 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Eastern Capital Ltd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total
  • ●
    Related company / holdingExecutivesiBio, Inc.
    6M USD6SEC
    28,925,000 shares@ US$0.209.6% of flowCommon StockSEC:0001408408-20-000047:0
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    5M USD6SEC
    1,355,604 shares@ US$3.82538.6% of flowCommon StockSEC:0001408408-20-000047:1
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    28M USD10SEC
    7,264,864 shares@ US$3.913347.7% of flowCommon StockSEC:0001408408-20-000047:2
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    46M USD0SEC
    15,864,436 shares@ US$2.9204Common StockSEC:0001408408-20-000047:3
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    3M USD5SEC
    600,000 shares@ US$4.39444.4% of flowCommon StockSEC:0001408408-20-000039:0
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    4M USD6SEC
    900,000 shares@ US$4.45956.7% of flowCommon StockSEC:0001408408-20-000039:1
  • ▼
    Related company / holdingExecutivesiBio, Inc.
    12M USD7SEC
    2,768,137 shares@ US$4.179919.2% of flowCommon StockSEC:0001408408-20-000039:2
  • ◆
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    500,000 USD13SEC
    416,667 shares@ US$1.20100.0% of flowCommon StockSEC:0001408408-20-000011:0
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    2M USD9SEC
    2,200,000 shares@ US$0.903.0% of flowCommon SharesSEC:0001408408-18-000018:0
    Canonical exit: 10 Oct 2018 (T+90)
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    2M USD7SEC
    1,683,334 shares@ US$0.902.3% of flowCommon SharesSEC:0001408408-18-000014:0
    Canonical exit: 24 Sept 2018 (T+90)
  • ▲
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    3M USD10SEC
    1,300,000 shares@ US$2.4049.2% of flowCommon StockSEC:0001408408-18-000007:0
    Canonical exit: 12 Aug 2018 (T+90)
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    2M USD5SEC
    12,000,000 shares@ US$0.203.4% of flowCommon StockSEC:0001408408-17-000036:0
    Canonical exit: 28 Feb 2018 (T+90)
  • ▲
    Related company / holdingExecutivesBio Green Med Solution, Inc.
    2M USD13SEC
    850,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001408408-17-000016:0
    Canonical exit: 17 Oct 2017 (T+90)
  • ●
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    0SEC
    3,000,000 sharesCommon StockSEC:0001408408-16-000084:1
  • ◆
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    3M USD9SEC
    5,000,000 shares@ US$0.5042.1% of flowCommon StockSEC:0001408408-16-000084:0
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    4M USD8SEC
    6,500,000 shares@ US$0.6226.0% of flowCommonSEC:0001408408-16-000077:0
    Canonical exit: 6 Jul 2016 (T+90)
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    2M USD13SEC
    3,500,000 shares@ US$0.622100.0% of flowCommon StockSEC:0001408408-16-000061:0
    Canonical exit: 24 Apr 2016 (T+90)
  • ◆
    Related company / holdingExecutivesiBio, Inc.
    0SEC
    1,784,000 sharesCommon StockSEC:0001408408-16-000061:1
  • ◆
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    2M USD0SEC
    10,000,000 shares@ US$0.20Common StockSEC:0001408408-15-000046:0
  • ◆
    Related company / holdingExecutivesMarker Therapeutics, Inc.
    3M USD0SEC
    5,000,000 shares@ US$0.50Common StockSEC:0001408408-15-000038:0
  • ●
    Related company / holdingExecutivesVericel Corp
    2M USD0SEC
    362,500 shares@ US$4.80Common StockSEC:0001408408-14-000009:0
  • ▲
    Related company / holdingExecutivesCytokinetics Inc
    4M USD0SEC
    500,000 shares@ US$8.00Common StockSEC:0001408408-14-000008:0
    Canonical exit: 26 May 2014 (T+90)
  • ●
    Related company / holdingExecutivesiBio, Inc.
    3M USD0SEC
    7,500,000 shares@ US$0.40Common StockSEC:0001408408-13-000022:0
  • ▲
    Related company / holdingExecutivesiBio, Inc.
    0SEC
    4,460,000 sharesCommon StockSEC:0001408408-13-000010:0
    Canonical exit: 25 Jul 2013 (T+90)

24 of 24 declarations